What Is New With Toys for Dementia Care in August 2026? Latest FDA, NIH, WHO, and CMS sources and Key Takeaways
Learn what agencies actually updated—and how to assess dementia toys for safe engagement, credible claims, and payment limits.
Steve Levine
Steve Levine brings hands-on caregiving and years of dementia research to HelpDementia.com. After becoming a supplementary caregiver for a grandparent diagnosed with early-onset Alzheimer's disease in 2023, he has spent hundreds of hours navigating the realities of cognitive decline — vascular dementia, Lewy body dementia, frontotemporal dementia, sundowning, behavioral changes, medication transitions, and the financial and emotional toll caregiving takes on families.
He writes about memory care, caregiver burnout, dementia-friendly activities, and emerging treatments for Parkinson's disease dementia and other forms of dementia, distilling lived experience and peer-reviewed research into practical guides families can actually use. His goal is simple: to give the next generation of caregivers the playbook he wishes he'd had on day one. Connect with Steve on LinkedIn.
Blog News for Dementia Care 2026 Guide: safety, access, and evidence limits; Key Facts and Questions to Ask
Use focused questions to assess dementia safety, treatment risks, evidence claims, and access to Medicare GUIDE support.
Toys for Dementia Care August 2026 Update: What Changed, Why It Matters, and What to Watch Next
Learn what 2026 evidence says about robotic pets, realistic benefits, person-led selection, and essential safety checks.
What Is New With Blog News for Dementia Care in August 2026? Latest FDA, NIH, WHO, and CMS sources and Key Takeaways
Understand which dementia advances affect care now, which remain experimental, and what families can ask next.
Blog News for Dementia Care August 2026 Update: What Changed, Why It Matters, and What to Watch Next
Understand new blood tests, GUIDE limits, caregiver tools, and the dementia-care policy gaps families should track.
PrecivityAD2 and Younger-Onset Alzheimer’s Diagnosis in 2026: What Adults With New Memory Symptoms Should Know About the News
Learn who PrecivityAD2 is for, what its amyloid result means, and why new memory symptoms still require a full evaluation.
The Third FDA-Cleared Alzheimer’s Blood Biomarker Test in 2026: What Adults With New Memory Symptoms Should Know About the News
Learn who qualifies for the newer blood tests, what their results mean, and what to ask during a memory evaluation.
PrecivityAD2 as an Adjunct to a 2026 Alzheimer’s Assessment: What Adults With New Memory Symptoms Should Know About the News
Learn who PrecivityAD2 is for, what its amyloid score can show, and which questions to ask before testing.
FDA’s 2026 PrecivityAD2 Alzheimer’s Blood Test Clearance: What Adults With New Memory Symptoms Should Know About the News
Learn who PrecivityAD2 is for, what each result can and cannot show, and what to ask before testing.
NIA’s 2026 Dementia Care Report on People Without Traditional Care Partners
Learn what NIA's report says—and does not yet establish—about dementia care for people without care partners.